Hiv antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells

HIGHLIGHTS

• who: Martine Auclair and collaborators from the Tenon Hospital, APHP, Paris, FranceSorbonne UniversityThe funders had no role in have published the paper: HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells, in the Journal: PLOS ONE | https://doi.org/10.1371/journal.pone [0226924]. January 23, 2020 of /1371/
• what: The aim of this paper was to further decipher the cellular pathways leading to inflammation, senescence and insulin sensitivity in HCAECs and which were altered by MVC, DTG and ATV . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.